Table 1.
Subjects’ details, dielectric characterization, and histopathology outcomes.
| Subject ID | Number of Excised Tissue Samples | Number of Points Analyzed | Mammographic Lesion’s BI-RADS Score | Probe Rule-of-Thumb Output | Histological Outcomes |
|---|---|---|---|---|---|
| 1 | 2 | 3 | 4A | Both samples positive (P) | No evidence of neoplasia (Benign) |
| 2 | 6 | 11 | 4B | 3 positive (P) and 3 negative (N) samples | Invasive ductal carcinoma, luminal (Malignant) in all analyzed samples |
| 3a (Left breast, inner quadrant) | 4 | 10 | 4B | 1 positive (P) and 3 negative (N) samples | Fibrosis (Benign) in all analyzed samples |
| 3b (Left breast, outer quadrant) | 4 | 6 | 4B | 2 positive (P) and 2 negative (N) samples | Fibrosis (Benign) in all analyzed samples |
| 4 | 5 | 11 | 5 | All samples positive (P) | Invasive ductal carcinoma (with in situ component) grade II, Her2- |
| 5 | 3 | 7 | 5 | All samples positive (P) | Invasive ductal carcinoma grade II, luminal |
| 6 | 3 | 10 | 5 | All samples positive (P) | Invasive ductal carcinoma (with in situ component) grade II, Her2+ |
| 7 | 2 | 16 | 3 | All samples negative (N) | Stromal collagenization compatible with stromal hyperplasia |
| 8 | 3 | 6 | 3 | All samples negative (N) | Benign fibroepithelial lesion in all analyzed samples |
| 9 | 5 | 13 | 5 | All samples positive (P) | Invasive ductal carcinoma (with in situ component) grade II |
| 10 | 3 | 8 | 5 | 2 positive (P) and 1 negative (N) samples | Invasive ductal carcinoma grade II in (A), adipose tissue in (B) |
| 11 | 5 | 12 | 5 | All samples positive (P) | Invasive ductal carcinoma grade II, intermediate luminal |
| 12a (Right Breast) | 3 | 8 | 5 | 1 positive (P) and 2 negative (N) samples | Microinvasive carcinoma grade I, luminal A |
| 12b (Left Breast) | 3 | 6 | 5 | 2 positive (P) and 1 negative (N) samples | Microinvasive carcinoma grade I, luminal A |
| 13 | 7 | 20 | 4B | 2 positive (P) and 5 negative (N) samples | Adenosis and mastopathy in all analyzed samples |
| 14 | 3 | 7 | 4B | 2 positive (P) and 1 negative (N) samples | Invasive ductal carcinoma grade II, luminal A in all analyzed samples |
| 15 | 3 | 8 | 5 | 3 positive (P) samples | Fibroadenoma in all analyzed samples |